Paragon debuts more COVID-19 NGS tests
October 19, 2020 -- Precision medicine firm Paragon Genomics has debuted two additional CleanPlex next-generation sequencing (NGS) tests to detect the novel coronavirus and estimate disease severity.
AbbVie gets FDA nod for new use of Venclexta
October 19, 2020 -- AbbVie has announced that the U.S. Food and Drug Administration (FDA) approved a new use of its B-cell lymphoma 2 inhibiting drug venetoclax (Venclexta) in the treatment of acute myeloid leukemia for some patients.
CMS to cut COVID-19 payments to slower labs
October 16, 2020 -- In a bid to speed up COVID-19 testing, the U.S. Centers for Medicare and Medicaid Services (CMS) has announced a new policy to pay for expedited COVID-19 test results. Starting January 1, Medicare will pay $100 only to labs that complete high-throughput COVID-19 diagnostic tests within two calendar days of specimens being collected.  Discuss
Blood test score helps predict COVID-19 severity
October 15, 2020 -- A team of researchers from the Royal College of Surgeons in Ireland University of Medicine and Health Sciences has developed a blood test score that can help predict COVID-19 disease severity, according to a study published on October 14 in EBioMedicine.
Cue secures $481M from DOD for COVID-19 tests
October 15, 2020 -- Cue Health has received $481 million from the U.S. Department of Defense (DOD) to produce and distribute 6 million point-of-care COVID-19 tests by March 2021.
Former CAP president named pathologist of the year
October 14, 2020 -- The College of American Pathologists (CAP) awarded former CAP president Dr. R. Bruce Williams with the Pathologist of the Year Award. Williams oversaw the organization as its 35th president from 2017-2019.
LabVantage secures U.S. government contract
October 14, 2020 -- LabVantage Solutions has won a contract from the U.S. Army Medical Research Acquisition Activity to supply its Pharma laboratory information management system to the Walter Reed Army Institute of Research.
Blood test could predict pregnancy complications
October 13, 2020 -- A blood test commonly used to detect fetal genetic abnormalities may help predict complications associated with pregnancy before symptoms develop, according to new research published in Epigenetics on October 13. Genetic material shed from the placenta into the mother's blood during the first trimester of pregnancy could potentially be used to predict possibly serious complications.
Qiagen sales, earnings climb in Q3
October 13, 2020 -- Significant ongoing demand for COVID-19 testing and improved trends in other areas of Qiagen's product portfolio led to a 26% increase in preliminary net sales for the company during its third quarter.
Beckman Coulter nabs EUA for COVID-19 IgM assay
October 9, 2020 -- The U.S. Food and Drug Administration has granted emergency use authorization (EUA) to Beckman Coulter's Access SARS-CoV-2 immunoglobulin M (IgM) assay, which detects antibodies that recognize the receptor-binding domain of the spike protein on the virus.